OVEREXPRESSION OF THE CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR IN NIH 3T3 CELLS LOWERS MEMBRANE-POTENTIAL AND INTRACELLULAR PH AND CONFERS A MULTIDRUG-RESISTANCE PHENOTYPE
Ly. Wei et al., OVEREXPRESSION OF THE CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR IN NIH 3T3 CELLS LOWERS MEMBRANE-POTENTIAL AND INTRACELLULAR PH AND CONFERS A MULTIDRUG-RESISTANCE PHENOTYPE, Biophysical journal, 69(3), 1995, pp. 883-895
Because of the similarities between the cystic fibrosis transmembrane
conductance regulator (CFTR) and multidrug resistance (MDR) proteins,
recent observations of decreased plasma membrane electrical potential
(Delta Psi) in cells overexpressing either MDR protein or the CFTR, an
d the effects of Delta Psi on passive diffusion of chemotherapeutic dr
ugs, we have analyzed chemotherapeutic drug resistance for NIH 3T3 cel
ls overexpressing different levels of functional CFTR. Three separate
clones not previously exposed to chemotherapeutic drugs exhibit resist
ance to doxorubicin, vincristine, and colchicine that is similar to MD
R transfectants not previously exposed to chemotherapeutic drugs. Two
other clones expressing lower levels of CFTR are less resistant. As sh
own previously these clones exhibit decreased plasma membrane Delta Ps
i similar to MDR transfectants, but four of five exhibit mildly acidif
ied intracellular pH in contrast to MDR transfectants, which are in ge
neral alkaline. Thus the MDR protein and CFTR-mediated MDR phenotypes
are distinctly different. Selection of two separate CFTR clones on eit
her doxorubicin or vincristine substantially increases the observed MD
R and leads to increased CFTR (but not measurable MDR or MRP) mRNA exp
ression. CFTR overexpressors also exhibit a decreased rate of H-3-vinb
lastine uptake. These data reveal a new and previously unrecognized co
nsequence of CFTR expression, and are consistent with the hypothesis t
hat membrane depolarization is an important determinant of tumor cell
MDR.